Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T21:50:31.923Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:50:31.923Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 146,622,028
TTM revenue · period ending 2026-06-30: 0

FMP input reference: 5d81df243028a463df18dadfb6b81954a95dec5b5738e9798e17a16434fd93e0

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

ABOS PS Ratio Metrics

PS RATIO

N/A

PS RATIO AVG TTM

N/A

PS RATIO AVG 3Y

N/A

PS RATIO AVG 5Y

N/A

PS RATIO AVG 10Y

N/A

PS RATIO AVG 15Y

N/A

PS RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

ABOS Competitors' PS Ratio

ABOS

Acumen Pharmaceuticals, Inc.

Current

Market Cap

$146.62M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDXS

Codexis, Inc.

vs ABOS

Market Cap

$146.28M

PS Ratio

1.88

TTM Avg

2.61

3Y Avg

3.23

5Y Avg

4.75

FBIOP

Fortress Biotech, Inc.

vs ABOS

Market Cap

$146.27M

PS Ratio

2.14

TTM Avg

7.67

3Y Avg

3.96

5Y Avg

3.05

AVXL

Anavex Life Sciences Corp.

vs ABOS

Market Cap

$148.27M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VYGR

Voyager Therapeutics, Inc.

vs ABOS

Market Cap

$148.64M

PS Ratio

4.31

TTM Avg

6.36

3Y Avg

3.87

5Y Avg

4.58

KRSA

Korsana Biosciences, Inc.

vs ABOS

Market Cap

$148.73M

PS Ratio

78.28

TTM Avg

4.90

3Y Avg

9.87

5Y Avg

13.41

ALXO

ALX Oncology Holdings Inc.

vs ABOS

Market Cap

$149.36M

PS Ratio

N/A

TTM Avg

1819.96

3Y Avg

1717.34

5Y Avg

1717.34

NGEN

NervGen Pharma Corp. Common stock

vs ABOS

Market Cap

$143.84M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TARA

Protara Therapeutics, Inc.

vs ABOS

Market Cap

$143.60M

PS Ratio

N/A

TTM Avg

79.91

3Y Avg

79.91

5Y Avg

79.91

NYXH

Nyxoah S.A.

vs ABOS

Market Cap

$143.10M

PS Ratio

5.46

TTM Avg

16.79

3Y Avg

41.83

5Y Avg

132.05

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Acumen Pharmaceuticals, Inc. (ABOS)	$146.62M	N/A	N/A	N/A	N/A
Codexis, Inc. (CDXS)vs ›	$146.28M	1.88	2.61	3.23	4.75
Fortress Biotech, Inc. (FBIOP)vs ›	$146.27M	2.14	7.67	3.96	3.05
Anavex Life Sciences Corp. (AVXL)vs ›	$148.27M	N/A	N/A	N/A	N/A
Voyager Therapeutics, Inc. (VYGR)vs ›	$148.64M	4.31	6.36	3.87	4.58
Korsana Biosciences, Inc. (KRSA)vs ›	$148.73M	78.28	4.90	9.87	13.41
ALX Oncology Holdings Inc. (ALXO)vs ›	$149.36M	N/A	1819.96	1717.34	1717.34
NervGen Pharma Corp. Common stock (NGEN)vs ›	$143.84M	N/A	N/A	N/A	N/A
Protara Therapeutics, Inc. (TARA)vs ›	$143.60M	N/A	79.91	79.91	79.91
Nyxoah S.A. (NYXH)vs ›	$143.10M	5.46	16.79	41.83	132.05

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

ABOS PS Ratio History

DATE	PS RATIO
2022-03-28	542.01
2022-03-25	597.84
2022-03-24	659.49
2022-03-23	659.49
2022-03-22	686.24
2022-03-21	697.87
2022-03-18	745.56
2022-03-17	722.30
2022-03-16	709.50
2022-03-15	635.06
2022-03-14	615.29
2022-03-11	640.88
2022-03-10	665.30
2022-03-09	689.73
2022-03-08	618.78
2022-03-07	615.29
2022-03-04	583.89
2022-03-03	635.06
2022-03-02	680.42
2022-03-01	710.67
2022-02-28	681.59
2022-02-25	665.30
2022-02-24	625.76
2022-02-23	658.32
2022-02-22	662.98
2022-02-18	687.40
2022-02-17	668.79
2022-02-16	678.10
2022-02-15	639.72
2022-02-14	596.68
2022-02-11	626.92
2022-02-10	651.35
2022-02-09	674.61
2022-02-08	636.23
2022-02-07	605.98
2022-02-04	579.23
2022-02-03	557.13
2022-02-02	579.23
2022-02-01	607.15
2022-01-31	595.52
2022-01-28	582.72
2022-01-27	564.11
2022-01-26	579.23
2022-01-25	592.03
2022-01-24	608.31
2022-01-21	602.50
2022-01-20	580.40
2022-01-19	603.66
2022-01-18	586.21
2022-01-14	625.76
2022-01-13	628.08
2022-01-12	611.80
2022-01-11	656.00
2022-01-10	640.88
2022-01-07	668.79
2022-01-06	666.47
2022-01-05	699.03
2022-01-04	740.91
2022-01-03	782.78
2021-12-31	786.27
2021-12-30	802.55
2021-12-29	773.47
2021-12-28	773.47
2021-12-27	794.41
2021-12-23	822.32
2021-12-22	818.84
2021-12-21	822.32
2021-12-20	809.53
2021-12-17	800.23
2021-12-16	807.20
2021-12-15	802.55
2021-12-14	760.68
2021-12-13	786.27
2021-12-10	818.84
2021-12-09	839.77
2021-12-08	885.13
2021-12-07	876.99
2021-12-06	867.69
2021-12-03	908.40
2021-12-02	945.62
2021-12-01	881.64
2021-11-30	918.86
2021-11-29	944.45
2021-11-26	961.90
2021-11-24	1046.81
2021-11-23	1046.81
2021-11-22	1128.22
2021-11-19	1146.83
2021-11-18	1196.85
2021-11-17	1252.68
2021-11-16	1248.03
2021-11-15	432.51
2021-11-12	472.65
2021-11-11	489.44
2021-11-10	515.72
2021-11-09	539.45
2021-11-08	532.15
2021-11-05	543.10
2021-11-04	537.62
2021-11-03	526.31
2021-11-02	494.19
2021-11-01	506.23
2021-10-29	512.80
2021-10-28	525.58
2021-10-27	532.51
2021-10-26	555.87
2021-10-25	525.94
2021-10-22	524.85
2021-10-21	531.42
2021-10-20	516.82
2021-10-19	506.60
2021-10-18	491.27
2021-10-15	494.55
2021-10-14	508.42
2021-10-13	525.21
2021-10-12	491.63
2021-10-11	477.76
2021-10-08	490.90
2021-10-07	540.18
2021-10-06	542.00
2021-10-05	558.79
2021-10-04	552.95
2021-10-01	557.33
2021-09-30	542.37
2021-09-29	542.00
2021-09-28	536.53
2021-09-27	581.05
2021-09-24	589.08
2021-09-23	588.35
2021-09-22	566.82
2021-09-21	548.94
2021-09-20	538.72
2021-09-17	592.37
2021-09-16	590.54
2021-09-15	559.52
2021-09-14	582.15
2021-09-13	585.07
2021-09-10	620.47
2021-09-09	646.02
2021-09-08	668.65
2021-09-07	668.29
2021-09-03	569.01
2021-09-02	557.33
2021-09-01	631.06
2021-08-31	654.05
2021-08-30	687.99
2021-08-27	681.79
2021-08-26	636.90
2021-08-25	628.14
2021-08-24	622.66
2021-08-23	641.64
2021-08-20	630.69
2021-08-19	609.16
2021-08-18	585.43
2021-08-17	562.44
2021-08-16	467.36
2021-08-13	463.69
2021-08-12	455.44
2021-08-11	452.99
2021-08-10	450.85
2021-08-09	459.72
2021-08-06	458.80
2021-08-05	458.19
2021-08-04	447.80
2021-08-03	456.97
2021-08-02	466.75
2021-07-30	473.17
2021-07-29	468.27
2021-07-28	455.44
2021-07-27	443.21
2021-07-26	506.48
2021-07-23	522.07
2021-07-22	523.60
2021-07-21	524.82
2021-07-20	565.78
2021-07-19	584.12
2021-07-16	545.91
2021-07-15	528.80
2021-07-14	560.58
2021-07-13	578.92
2021-07-12	565.48
2021-07-09	577.70
2021-07-08	543.47
2021-07-07	573.12
2021-07-06	617.44
2021-07-02	619.88
2021-07-01	614.38

Fiscal period	Revenue	Source
Q3 FY2025Period ended 2025-09-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12
Q4 FY2025Period ended 2025-12-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-26
Q1 FY2026Period ended 2026-03-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12
Q2 FY2026Period ended 2026-06-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12
TTM revenue	$0

PS Ratio: N/A

ABOS PS Ratio Chart

ABOS PS Ratio Metrics

ABOS Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

ABOS PS Ratio History

Related Metrics